BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 17895248)

  • 1. The ADAM10 prodomain is a specific inhibitor of ADAM10 proteolytic activity and inhibits cellular shedding events.
    Moss ML; Bomar M; Liu Q; Sage H; Dempsey P; Lenhart PM; Gillispie PA; Stoeck A; Wildeboer D; Bartsch JW; Palmisano R; Zhou P
    J Biol Chem; 2007 Dec; 282(49):35712-21. PubMed ID: 17895248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein.
    Moss ML; Powell G; Miller MA; Edwards L; Qi B; Sang QX; De Strooper B; Tesseur I; Lichtenthaler SF; Taverna M; Zhong JL; Dingwall C; Ferdous T; Schlomann U; Zhou P; Griffith LG; Lauffenburger DA; Petrovich R; Bartsch JW
    J Biol Chem; 2011 Nov; 286(47):40443-51. PubMed ID: 21956108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency.
    Hinkle CL; Sunnarborg SW; Loiselle D; Parker CE; Stevenson M; Russell WE; Lee DC
    J Biol Chem; 2004 Jun; 279(23):24179-88. PubMed ID: 15066986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of sigma-1 receptor inhibits ADAM10 and ADAM17 mediated shedding in vitro.
    Li J; Liu B; Gao X; Ma Z; CaoSong T; Mei YA; Zheng Y
    Protein Cell; 2012 Feb; 3(2):153-9. PubMed ID: 22322890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-1 (IGF-1)-induced processing of amyloid-beta precursor protein (APP) and APP-like protein 2 is mediated by different metalloproteinases.
    Jacobsen KT; Adlerz L; Multhaup G; Iverfeldt K
    J Biol Chem; 2010 Apr; 285(14):10223-31. PubMed ID: 20139073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx.
    Horiuchi K; Le Gall S; Schulte M; Yamaguchi T; Reiss K; Murphy G; Toyama Y; Hartmann D; Saftig P; Blobel CP
    Mol Biol Cell; 2007 Jan; 18(1):176-88. PubMed ID: 17079736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGF promotes the shedding of soluble E-cadherin in an ADAM10-dependent manner in prostate epithelial cells.
    Grabowska MM; Sandhu B; Day ML
    Cell Signal; 2012 Feb; 24(2):532-538. PubMed ID: 22024284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer.
    Pruessmeyer J; Ludwig A
    Semin Cell Dev Biol; 2009 Apr; 20(2):164-74. PubMed ID: 18951988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAM10 as a target for anti-cancer therapy.
    Moss ML; Stoeck A; Yan W; Dempsey PJ
    Curr Pharm Biotechnol; 2008 Feb; 9(1):2-8. PubMed ID: 18289051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The "A Disintegrin And Metalloproteases" ADAM10 and ADAM17: novel drug targets with therapeutic potential?
    Saftig P; Reiss K
    Eur J Cell Biol; 2011; 90(6-7):527-35. PubMed ID: 21194787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition.
    Rapti M; Atkinson SJ; Lee MH; Trim A; Moss M; Murphy G
    Biochem J; 2008 Apr; 411(2):433-9. PubMed ID: 18215140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands.
    Sahin U; Weskamp G; Kelly K; Zhou HM; Higashiyama S; Peschon J; Hartmann D; Saftig P; Blobel CP
    J Cell Biol; 2004 Mar; 164(5):769-79. PubMed ID: 14993236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ectodomain shedding of TNF-alpha is enhanced by nardilysin via activation of ADAM proteases.
    Hiraoka Y; Yoshida K; Ohno M; Matsuoka T; Kita T; Nishi E
    Biochem Biophys Res Commun; 2008 May; 370(1):154-8. PubMed ID: 18355445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytoplasmic domain of a disintegrin and metalloproteinase 10 (ADAM10) regulates its constitutive activity but is dispensable for stimulated ADAM10-dependent shedding.
    Maretzky T; Evers A; Le Gall S; Alabi RO; Speck N; Reiss K; Blobel CP
    J Biol Chem; 2015 Mar; 290(12):7416-25. PubMed ID: 25605720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.
    Chitadze G; Lettau M; Bhat J; Wesch D; Steinle A; Fürst D; Mytilineos J; Kalthoff H; Janssen O; Oberg HH; Kabelitz D
    Int J Cancer; 2013 Oct; 133(7):1557-66. PubMed ID: 23526433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The xenoestrogens biphenol-A and nonylphenol differentially regulate metalloprotease-mediated shedding of EGFR ligands.
    Urriola-Muñoz P; Li X; Maretzky T; McIlwain DR; Mak TW; Reyes JG; Blobel CP; Moreno RD
    J Cell Physiol; 2018 Mar; 233(3):2247-2256. PubMed ID: 28703301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10.
    Abel S; Hundhausen C; Mentlein R; Schulte A; Berkhout TA; Broadway N; Hartmann D; Sedlacek R; Dietrich S; Muetze B; Schuster B; Kallen KJ; Saftig P; Rose-John S; Ludwig A
    J Immunol; 2004 May; 172(10):6362-72. PubMed ID: 15128827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8.
    Naus S; Reipschläger S; Wildeboer D; Lichtenthaler SF; Mitterreiter S; Guan Z; Moss ML; Bartsch JW
    Biol Chem; 2006 Mar; 387(3):337-46. PubMed ID: 16542157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes.
    Hundhausen C; Schulte A; Schulz B; Andrzejewski MG; Schwarz N; von Hundelshausen P; Winter U; Paliga K; Reiss K; Saftig P; Weber C; Ludwig A
    J Immunol; 2007 Jun; 178(12):8064-72. PubMed ID: 17548644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrocyclic θ-defensins suppress tumor necrosis factor-α (TNF-α) shedding by inhibition of TNF-α-converting enzyme.
    Schaal JB; Maretzky T; Tran DQ; Tran PA; Tongaonkar P; Blobel CP; Ouellette AJ; Selsted ME
    J Biol Chem; 2018 Feb; 293(8):2725-2734. PubMed ID: 29317500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.